Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

15.85
Delayed Data
As of 3:59pm ET
 +0.04 / +0.25%
Today’s Change
7.20
Today|||52-Week Range
17.19
+59.78%
Year-to-Date
3 Small Biotech Value Plays
May 17 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close15.81
Today’s open15.79
Day’s range15.66 - 16.47
Volume299,520
Average volume (3 months)550,460
Market cap$694.7M
Dividend yield--
Data as of 3:59pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)+17.50%
Earnings growth (this year)+24.14%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+208.07%
P/E ratioNM
Price/Sales9.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...+0.02+0.13%
ACORAcorda Therapeutics ...-0.20-1.31%
LCILannett Company Inc-0.05-0.25%
TGTXTG Therapeutics Inc+0.50+4.37%
Data as of 4:00pm ET, 05/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$41.6M
Annual profit (last year)-$66.7M
Net profit margin-160.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts